2025-03-05 - Analysis Report
## Procter & Gamble Co (PG) Stock Review

**0. Summary of Key Figures:**

* **Cumulative Return (PG):** 84.82%
* **Cumulative Return (VOO):** 108.99%
* **Return Difference (PG vs VOO):** -24.2%  (Relative Difference: 27.0%)
* **Current Price:** $173.18
* **5-day Moving Average:** $173.18
* **20-day Moving Average:** $169.64
* **60-day Moving Average:** $167.23
* **RSI:** 56.81
* **PPO:** 0.33
* **Expected Return (vs S&P 500, long-term):** -7.9%


**1. Performance Comparison:**

Procter & Gamble Co (PG) is a consumer staples company that produces and markets a wide variety of household and personal care products.  Over the analyzed period, PG underperformed the S&P 500 (VOO) by 24.2%, placing it at the 27th percentile of its historical relative performance against the S&P 500 based on the provided data.  While consistently profitable, its growth lagged behind the broader market.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 21.0% | 2.0% | -8.0% | 0.1 | 177.8 |
| 2016-2018  | 13.0% | 6.8% | -6.0% | 0.3 | 184.2 |
| 2017-2019  | 43.0% | 6.8% | 13.0% | 0.8 | 257.3 |
| 2018-2020  | 58.0% | 8.2% | 30.0% | 0.3 | 293.7 |
| 2019-2021  | 65.0% | 8.2% | -6.0% | 0.2 | 354.0 |
| 2020-2022  | 15.0% | 8.2% | 7.0% | 0.2 | 336.1 |
| 2021-2023  | 8.0% | 8.4% | -16.0% | 0.5 | 333.2 |
| 2022-2024  | -5.0% | 8.4% | -38.0% | 0.4 | 390.7 |
| 2023-2025  | 25.0% | 8.4% | -25.0% | 0.2 | 406.1 |

The table shows varying CAGR (Compound Annual Growth Rate) and Alpha (excess return compared to the benchmark) across different periods.  Beta, a measure of volatility relative to the market, is generally low, indicating lower risk than the broader market.  However, the negative alpha values in several periods highlight the underperformance relative to the benchmark.


**2. Recent Price Movement:**

The stock price recently closed at $173.18, down $1.37 from the previous close. This represents a short-term decline.  The 5-day moving average ($173.18) suggests recent stability, while the 20-day ($169.64) and 60-day ($167.23) moving averages indicate a slightly upward trend.


**3. Technical Indicators:**

* **RSI (56.81):**  Indicates the stock is neither overbought nor oversold, suggesting a neutral sentiment.
* **PPO (0.33):** A positive value suggests bullish momentum.
* **20-day Relative Strength:** The positive change of 8.1 points suggests short-term upward momentum.
* **Expected Return:** A -7.9% expected return over the long term against the S&P 500 indicates underperformance. The recent price drop further contributes to this negative outlook.  There is no significant evidence of a sudden jump or drop.

**4. Recent Earnings Analysis:**

| 날짜       | EPS    | 매출       |
|------------|--------|------------|
| 2025-01-22 | 1.94   | 21.88 B$   |
| 2024-10-18 | 1.65   | 21.74 B$   |
| 2024-04-19 | 1.56   | 20.20 B$   |
| 2024-01-23 | 1.44   | 21.44 B$   |
| 2025-01-22 | 1.44   | 21.44 B$   |

There appears to be an error in the data; two entries are listed for 2025-01-22.  Ignoring the duplicate,  EPS and revenue show some fluctuation but a general upward trend. Further analysis is needed for better insights (e.g., comparing YoY and QoQ growth rates).


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue     | Profit Margin |
|-------------|-------------|---------------|
| 2024-12-31 | $21.88B     | 52.39%        |
| 2024-09-30 | $21.74B     | 52.06%        |
| 2024-06-30 | $20.53B     | 49.60%        |
| 2024-03-31 | $20.20B     | 51.20%        |
| 2023-12-31 | $21.44B     | 52.69%        |

Revenue is relatively stable, with a slight decline in Q2 2024. Profit margins are consistently high but have shown some fluctuation.


**Capital and Profitability:**

| Quarter     | Equity      | ROE           |
|-------------|-------------|---------------|
| 2024-12-31 | $51.17B     | 9.05%         |
| 2024-09-30 | $51.84B     | 7.64%         |
| 2024-06-30 | $50.29B     | 6.24%         |
| 2024-03-31 | $50.06B     | 7.50%         |
| 2023-12-31 | $48.53B     | 7.15%         |

Equity shows some fluctuations. ROE (Return on Equity) also fluctuates but generally remains healthy, indicating effective use of shareholder capital.



**6. Overall Analysis:**

PG demonstrates consistent profitability and strong financial fundamentals. However, its recent performance has lagged behind the S&P 500, resulting in a negative alpha and a lower cumulative return. While the technical indicators suggest a neutral to slightly bullish short-term outlook, the negative long-term expected return warrants caution.  The data suggests that a long-term investment in PG may underperform the S&P 500. Further investigation into the reasons for underperformance against the broader market and clarification of the duplicated data point are recommended before making investment decisions.  A more comprehensive analysis, incorporating additional factors like industry trends and future growth projections, is crucial for a complete assessment.
